Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for EWTX

Stock NameEdgewise Therapeutics Inc
TickerEWTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS28036F1057

Show aggregate EWTX holdings

News associated with EWTX

JPMorgan Chase & Co. Lowers Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $30.00
Edgewise Therapeutics (NASDAQ:EWTX – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $40.00 to $30.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research analysts have also issued reports on EWTX. Royal Bank Of […] - 2025-08-20 03:02:43
TD Asset Management Inc Invests $730,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
TD Asset Management Inc acquired a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 33,200 shares of the company’s stock, valued at approximately $730,000. Several other institutional investors also recently modified […] - 2025-08-05 04:37:18
Arizona State Retirement System Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Arizona State Retirement System raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,201 shares of the company’s stock after purchasing an additional 1,338 shares during the quarter. Arizona […] - 2025-07-23 05:44:46
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Arizona State Retirement System
Arizona State Retirement System boosted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,201 shares of the company’s stock after acquiring an additional 1,338 shares during the period. Arizona […] - 2025-07-23 04:52:54
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.00
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year […] - 2025-07-08 02:38:53
HC Wainwright Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX)
HC Wainwright began coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a “buy” rating and a $42.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 227.61% from the company’s previous close. Several […] - 2025-07-02 02:34:45
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Consensus PT from Brokerages
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers […] - 2025-06-13 02:14:54
Squarepoint Ops LLC Purchases 9,729 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Squarepoint Ops LLC lifted its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,358 shares of the company’s stock after buying an additional 9,729 shares during the quarter. Squarepoint Ops LLC’s […] - 2025-06-03 05:04:51
Two Sigma Investments LP Reduces Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Two Sigma Investments LP lowered its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 49.6% in the 4th quarter, HoldingsChannel reports. The fund owned 131,667 shares of the company’s stock after selling 129,791 shares during the period. Two Sigma Investments LP’s holdings in Edgewise Therapeutics were worth $3,516,000 at the end of the […] - 2025-05-30 05:27:09
Nuveen Asset Management LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Nuveen Asset Management LLC raised its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 428,858 shares of the company’s stock after purchasing an additional 158,452 shares during the quarter. Nuveen Asset Management LLC’s holdings in Edgewise Therapeutics were worth $11,451,000 at […] - 2025-05-28 04:58:59
BNP Paribas Financial Markets Buys Shares of 33,082 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
BNP Paribas Financial Markets purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 33,082 shares of the company’s stock, valued at approximately $883,000. Several other large investors have also recently made changes to their positions in EWTX. First Light Asset Management […] - 2025-05-22 04:38:48
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month […] - 2025-05-16 02:58:59
The Manufacturers Life Insurance Company Has $1.07 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
The Manufacturers Life Insurance Company increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,170 shares of the company’s stock after purchasing an additional 1,760 shares during the period. The Manufacturers […] - 2025-05-14 04:46:53
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD boosted its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 22.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,050 shares of the company’s stock after purchasing an additional 5,242 shares […] - 2025-05-12 05:18:50
Dimensional Fund Advisors LP Grows Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Dimensional Fund Advisors LP grew its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 729,923 shares of the company’s stock after buying an additional 3,052 shares during […] - 2025-05-08 04:50:47
Envestnet Asset Management Inc. Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Envestnet Asset Management Inc. increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 14,678 shares of the company’s stock after purchasing an additional 3,561 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Edgewise Therapeutics were worth $392,000 at the end […] - 2025-05-06 04:24:53
Edgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at Guggenheim
Guggenheim initiated coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $41.00 price target on the stock. Guggenheim’s price target suggests a potential upside of 145.80% from the stock’s current price. Other […] - 2025-05-02 05:02:53
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Invesco Ltd. lowered its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 43,435 shares of the company’s stock after selling 21,341 shares during the quarter. Invesco Ltd.’s holdings in Edgewise Therapeutics were worth $1,160,000 as of its most recent […] - 2025-05-02 04:26:44
Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Marshall Wace LLP reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 94.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the company’s stock after selling 547,672 shares during the period. […] - 2025-05-01 05:43:00
Barclays PLC Has $3.57 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Barclays PLC grew its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 133,657 shares of the company’s stock after purchasing an additional 14,307 shares during the quarter. Barclays PLC’s holdings in Edgewise Therapeutics were worth $3,568,000 at the end of the […] - 2025-04-29 05:08:56
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.38 Average PT from Brokerages
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month […] - 2025-04-24 02:10:55
Edgewise Therapeutics (NASDAQ:EWTX) Receives “Outperform” Rating from Wedbush
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $43.00 price objective on the stock. Wedbush’s price target points to a potential upside of 217.81% from the company’s previous close. Several other research […] - 2025-04-23 03:00:59
Alliancebernstein L.P. Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Alliancebernstein L.P. increased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,260 shares of the company’s stock after purchasing an additional 1,300 shares during the period. Alliancebernstein L.P.’s holdings […] - 2025-04-17 04:30:59
Geode Capital Management LLC Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Geode Capital Management LLC grew its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,600,571 shares of the company’s stock after purchasing an additional 1,036 shares during the quarter. Geode […] - 2025-04-15 05:08:57
Orion Portfolio Solutions LLC Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Orion Portfolio Solutions LLC decreased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 8.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 11,928 shares of the company’s stock after selling 1,083 shares during the period. Orion Portfolio Solutions LLC’s holdings in Edgewise Therapeutics were worth $318,000 at the […] - 2025-04-10 05:38:57
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Acquires $10,000,000.23 in Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) Director Orbimed Advisors Llc acquired 496,771 shares of Edgewise Therapeutics stock in a transaction that occurred on Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, with a total value of $10,000,000.23. Following the completion of the acquisition, the director now […] - 2025-04-07 06:28:50
Scotiabank Downgrades Edgewise Therapeutics (NASDAQ:EWTX) to Sector Perform
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research report issued on Wednesday, Marketbeat.com reports. They currently have a $14.00 target price on the stock, down from their prior target price of $50.00. Scotiabank’s price target would […] - 2025-04-04 03:14:47
Noteworthy Wednesday Option Activity: EWTX, PACK, ORCL
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Edgewise Therapeutics Inc (Symbol: EWTX), where a total of 15,988 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to - 2025-04-02 16:27:28
Teacher Retirement System of Texas Has $298,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Teacher Retirement System of Texas raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 18.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,143 shares of the company’s stock after purchasing an […] - 2025-04-02 04:42:47
Quantbot Technologies LP Purchases Shares of 3,855 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Quantbot Technologies LP purchased a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 3,855 shares of the company’s stock, valued at approximately $103,000. Other institutional investors have also recently made changes to their positions […] - 2025-04-01 04:54:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc EWTX holdings

DateNumber of EWTX Shares HeldBase Market Value of EWTX SharesLocal Market Value of EWTX SharesChange in EWTX Shares HeldChange in EWTX Base ValueCurrent Price per EWTX Share HeldPrevious Price per EWTX Share Held
2025-09-26 (Friday)23,277USD 373,596USD 373,596
2025-09-25 (Thursday)23,277USD 346,478EWTX holding decreased by -39687USD 346,4780USD -39,687 USD 14.885 USD 16.59
2025-09-24 (Wednesday)23,277USD 386,165USD 386,165
2025-09-17 (Wednesday)23,127USD 321,234EWTX holding decreased by -3932USD 321,2340USD -3,932 USD 13.89 USD 14.06
2025-09-16 (Tuesday)23,127USD 325,166USD 325,166
2025-09-12 (Friday)22,977USD 327,192USD 327,192
2025-09-11 (Thursday)22,977USD 337,073USD 337,073
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EWTX by Blackrock for IE00B3VWM098

Show aggregate share trades of EWTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-75 14.620* 21.56 Profit of 1,617 on sale
2025-07-31BUY225 14.260* 21.65
2025-06-30SELL-150 13.110* 22.70 Profit of 3,405 on sale
2025-06-25SELL-75 14.330* 22.90 Profit of 1,717 on sale
2025-06-20SELL-150 14.300* 23.08 Profit of 3,462 on sale
2025-05-23BUY75 14.210* 24.47
2025-05-19SELL-75 14.790* 24.81 Profit of 1,861 on sale
2025-05-15SELL-225 14.450* 24.99 Profit of 5,622 on sale
2025-05-12SELL-75 14.820* 25.26 Profit of 1,895 on sale
2025-05-09SELL-75 14.580* 25.36 Profit of 1,902 on sale
2025-04-30SELL-75 16.400* 26.01 Profit of 1,951 on sale
2025-04-24SELL-150 15.400* 26.44 Profit of 3,967 on sale
2025-04-17SELL-75 13.450* 27.12 Profit of 2,034 on sale
2025-04-15SELL-225 13.020* 27.43 Profit of 6,171 on sale
2025-04-14SELL-225 12.330* 27.59 Profit of 6,209 on sale
2025-04-09SELL-300 12.500* 28.13 Profit of 8,439 on sale
2025-04-07SELL-532 11.830* 28.51 Profit of 15,170 on sale
2025-04-04SELL-760 11.510* 28.71 Profit of 21,823 on sale
2025-03-31BUY76 22.000* 29.06
2025-03-19SELL-152 24.590* 29.67 Profit of 4,511 on sale
2025-03-14SELL-456 25.670* 29.82 Profit of 13,598 on sale
2025-03-13SELL-152 25.280* 29.89 Profit of 4,543 on sale
2025-03-12SELL-2,584 25.190* 29.95 Profit of 77,401 on sale
2025-03-07SELL-152 28.010* 30.06 Profit of 4,569 on sale
2025-03-06SELL-228 28.130* 30.09 Profit of 6,860 on sale
2025-03-03SELL-76 25.530* 30.31 Profit of 2,303 on sale
2025-02-28SELL-26,226 26.170* 30.37 Profit of 796,606 on sale
2025-02-26SELL-144 25.570* 30.52 Profit of 4,395 on sale
2025-02-25SELL-432 25.080* 30.62 Profit of 13,227 on sale
2025-02-18BUY720 26.130* 31.02
2025-02-13BUY144 26.020* 31.34
2025-02-12BUY144 25.850* 31.45
2025-02-11BUY432 26.160* 31.56
2025-02-06BUY1,296 28.690* 31.86
2025-01-27BUY144 27.850* 32.59
2024-12-30BUY720 27.055* 33.22
2024-12-06BUY576 32.590* 33.47
2024-12-05BUY144 31.570* 33.54
2024-12-04BUY720 32.060* 33.59
2024-11-29BUY720 33.000* 33.76
2024-11-27BUY576 32.200* 33.90
2024-11-26SELL-2,226 32.080* 33.98 Profit of 75,635 on sale
2024-11-25SELL-7,110 31.980* 34.07 Profit of 242,261 on sale
2024-11-21BUY865 31.980* 34.28
2024-11-20BUY519 31.950* 34.41
2024-11-18BUY2,066 30.790* 34.82
2024-11-12BUY1,376 35.200* 34.79
2024-11-08BUY860 36.380* 34.68
2024-11-07BUY2,580 35.430* 34.62
2024-11-06BUY344 36.620* 34.46
2024-10-31BUY172 33.570* 34.44
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EWTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19151,1380266,75956.7%
2025-09-18299,0863,699715,95441.8%
2025-09-1785,6730187,06745.8%
2025-09-16107,2670205,73052.1%
2025-09-15103,2858,072172,99059.7%
2025-09-12110,5330154,79471.4%
2025-09-11210,9799,705313,84167.2%
2025-09-1083,057286215,10138.6%
2025-09-09136,8130242,64356.4%
2025-09-08178,475800250,27371.3%
2025-09-05125,4350296,39942.3%
2025-09-04110,4350200,42155.1%
2025-09-03285,5890509,99556.0%
2025-09-02138,5070509,98027.2%
2025-08-29122,3600254,03648.2%
2025-08-28739,8520812,27991.1%
2025-08-27113,9920277,82841.0%
2025-08-26600,11001,695,66935.4%
2025-08-25147,4280175,88183.8%
2025-08-2297,1993,000158,89761.2%
2025-08-21186,8018,916288,59064.7%
2025-08-2090,4230112,06080.7%
2025-08-19168,4000225,30574.7%
2025-08-18101,4270142,64671.1%
2025-08-1571,6780132,12954.2%
2025-08-1465,8740119,44955.1%
2025-08-1365,0710242,94926.8%
2025-08-12120,62035,365504,42223.9%
2025-08-11112,3830165,88667.7%
2025-08-0888,2200182,99848.2%
2025-08-07129,711292209,60561.9%
2025-08-0691,20214145,01562.9%
2025-08-05117,3580203,70957.6%
2025-08-04133,5560351,25438.0%
2025-08-01168,1742,682212,55779.1%
2025-07-31127,9770171,12974.8%
2025-07-30228,806275441,91551.8%
2025-07-29118,8101,021226,39952.5%
2025-07-2895,9170204,80746.8%
2025-07-25173,8520257,27267.6%
2025-07-2488,41228140,89862.7%
2025-07-2386,43624217,26639.8%
2025-07-2253,712075,17171.5%
2025-07-2144,608073,91160.4%
2025-07-1864,350089,87871.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.